Engineered for Stability: The Advantage of Bilayer Technology
Our Levocetirizine and Montelukast combination formulation utilizes advanced Bilayer Tablet Technology to ensure maximum product integrity and therapeutic effect. We recognize that Montelukast is a sensitive molecule that can degrade when in direct physical contact with other active ingredients over time. By physically separating Montelukast and Levocetirizine into two distinct, independent layers within a single tablet, our bilayer design prevents chemical interaction. This ensures that both critical components remain stable and potent throughout the product's shelf-life, delivering consistent, reliable relief to the patient with every dose.
This advanced formulation combines three potent active ingredients to provide comprehensive relief in moderate to severe painful inflammatory conditions. It synergizes the established analgesic and anti-inflammatory properties of Aceclofenac and Paracetamol with the powerful enzymatic action of Serratiopeptidase.
"Breathe easier with ARZFLO AZ—the premium dual-action solution for comprehensive nasal relief."
Dual-Action Efficacy: Combines a fast-acting antihistamine (Azelastine) and a potent corticosteroid (Fluticasone) to rapidly halt both the allergic response and underlying inflammation.
Precision Delivery: Guarantees 70 exact, metered doses. Every spray delivers a highly consistent therapeutic concentration directly to the nasal mucosa.
Uncompromising Quality: Manufactured in a WHO-GMP certified facility, ensuring premium safety, purity, and manufacturing excellence.
Patient-Centric Design: Ergonomically designed for simple intranasal administration, maximizing local efficacy while minimizing systemic absorption.
Luliconazole IP 1% w/w | 50g
Broad-spectrum antifungal relief. Pure. Precise. Proven.
Premium API: Formulated with the highest-grade active ingredients for maximum clinical potency.
Top-Tier Manufacturing: Precision-crafted in India’s leading state-of-the-art facilities.
Uninterrupted Care: A generous 50g volume designed to ensure complete treatment cycles.
This advanced formulation addresses Gastroesophageal Reflux Disease (GERD) complicated by dysmotility through a state-of-the-art Tablet-in-Capsule delivery system.